Boosh Plant-Based Brands Receives FINRA Clearance Letter; Submits OTCQB Application Biotech Investing
Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology Cannabis Investing News
Seelos Therapeutics Doses First Patient in Part 2 of a Registrational Study of SLS-002 for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder Psychedelics Investing
Knight Therapeutics Announces Health Canada Approval for NERLYNX® to Treat HER2-Positive Metastatic Breast Cancer Medical Device Investing
Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3 Medical Device Investing
Trillium Therapeutics Announces Dosing of First Patient in Phase 1b/2 Study of TTI-622 in Combination With Azacitidine and Venetoclax in TP53-Wild Type Acute Myeloid Leukemia Biotech Investing
FDA Approves Expanded Indication for Merck's KEYTRUDA® in Locally Advanced Cutaneous Squamous Cell Carcinoma Pharmaceutical Investing
Lexaria Announces Voluntary Delisting from the Canadian Securities Exchange to Concentrate Trading on the Nasdaq Capital Markets Biotech Investing
Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories Pharmaceutical Investing
